Edmund C. Lee - Concepedia

Author

Edmund C. Lee

Regulus Therapeutics (United States)ORCID

Also Known As

Edmund C. Lee

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Regulus Therapeutics (United States)The University of Texas Southwestern Medical Center University of Kansas Medical Center

About

Edmund C. Lee is an author at Regulus Therapeutics (United States) specializing in immunology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	526
2	Immunology	2	2	526
3	Health Sciences	1	1	488
4	Biomolecular Engineering	1	1	38
5	Molecular Biology	1	1	488

Edmund C. Lee

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer Erik Kupperman, Edmund C. Lee, Yueying Cao, Cancer Research Proteasome Inhibitor Mln9708Antitumor ActivityImmunologyProteasomeMolecular Biology	2010	488
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism Sachin Hajarnis, Ronak Lakhia, Matanel Yheskel, Nature Communications	2017	195
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease Edmund C. Lee, Tania Valencia, Charles Allerson, Nature Communications	2019	185
Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies Edmund C. Lee, Michael Fitzgerald, Bret Bannerman, Clinical Cancer Research	2011	106
PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression Ronak Lakhia, Harini Ramalingam, Chun-Mien Chang, Nature Communications	2022	66
Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain Robert F. Kester, Andrew F. Donnell, Yan Lou, Journal of Medicinal Chemistry X-linked InhibitorXiap Bir3Drug TargetApoptosis ProteinXiap Bir3 Inhibitors	2013	38
Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth Xinqiang Huang, Jill Magnus, Vivek Kaimal, Molecular Cancer Therapeutics	2017	21

Page 1